While the country races to create a vaccine for 2019 coronavirus disease (COVID-19), some researchers have turned to medications approved to treat heart disease in hopes they can prevent or reduce complications from COVID-19.

Jeffrey S. Berger, MD, director of the Center for the Prevention of Cardiovascular Disease at NYU Langone, discusses his clinical trial to determine whether blood thinners, like aspirin, are more effective at preventing blood clots or death when used at high doses rather than low doses.

Dr. Berger notes that there are a number of people with COVID-19, without a history of cardiovascular disease, who develop blood clots in the lungs and legs. “While it is less common, it is not infrequent,” he says. “That is what is so concerning with this disease.”

Read more from The Wall Street Journal (subscription required).